le samedi 21 juillet 2018, à 22:18. Posté
par Shawn
Through friends http://locadeco.net/abr-pharma-5e4f.pdf#sexual abr pharmaceuticals Brokerage Susquehanna raised its rating on the chipmaker'sstock to "positive" from "neutral" and its price target to $35from $33, citing a pickup in telecom spending and product cycleramps at key mobile customers such as Apple Inc andSamsung Electronics Co Ltd.